Professor of Surgery
University of California, San Francisco
Professor of Surgery
University of California, San Francisco
San Francisco, California
Session Moderator
SESSION 24: NEW DEVELOPMENTS IN ATHERECTOMY, STENTS (UNCOATED, COATED AND BIORESORBABLE)
Presenter
SESSION 23: GENERALITIES IN THE ENDOVASCULAR AND OPEN TREATMENT OF LOWER EXTREMITY OCCLUSIVE DISEASE AND CLTI
Presenter
SESSION 27: PROGRESS IN EXOTIC AND EXTREME NEW TREATMENTS FOR VERY DISTAL LOWER EXTREMITY DISEASE CAUSING ADVANCED CLTI: OPTIONS TO SAVE THE “NO OPTION FOR TREATMENT” LIMB AND THE “DESERT FOOT”
Presenter
SESSION 26: NEW DEVELOPMENTS IN DRUG COATED BALLOONS (DCBS) AND DRUG ELUTING STENTS (DESS): UPDATES ON RANDOMIZED CONTROLLED TRIALS (RCTS) AND BTK LESION TREATMENTS WITH DCBS AND DESS
Presenter
SESSION 25: LOWER EXTREMITY TOPICS RELATED TO DRUG COATED BALLOONS (DCBS), AND DRUG ELUTING STENTS (DESS) AND OTHER INTERWOVEN (SUPERA) STENTS
Presenter
SESSION 35: RECORDED LIVE CHALLENGING CASES AND INNOVATIVE TECHNIQUES FROM THE PLINIO ROSSI AND LINC COMPONENTS
Presenter
SESSION 78: CAROTID ARTERY THERAPY STARS AND LATEST TRENDS
Presenter
SESSION 80: NEW DEVELOPMENTS IN THE TREATMENT OF CAROTID STENOSIS: UPDATE ON MESH COVERED STENTS AND TCAR (TRANSCERVICAL CAROTID ARTERY REVASCULARIZATION)
Session Moderator
SESSION 106: MISCELLANEOUS/GENERAL TOPICS AND LOWER EXTREMITY TOPICS TOO IMPORTANT TO MISS
Presenter
SESSION 106: MISCELLANEOUS/GENERAL TOPICS AND LOWER EXTREMITY TOPICS TOO IMPORTANT TO MISS
Presenter
SESSION 107: MORE LOWER EXTREMITY TOPICS TOO IMPORTANT TO MISS
SESSION 24: NEW DEVELOPMENTS IN ATHERECTOMY, STENTS (UNCOATED, COATED AND BIORESORBABLE)
Presenter
SESSION 23: GENERALITIES IN THE ENDOVASCULAR AND OPEN TREATMENT OF LOWER EXTREMITY OCCLUSIVE DISEASE AND CLTI
Microembolization During Complex Endovascular Procedures Is Causing More Damage Than We Think To The Already Compromised Pedal Runoff: Is Paclitaxel A Causal Agent
7:28 AM - 7:33 AM
Presenter
SESSION 27: PROGRESS IN EXOTIC AND EXTREME NEW TREATMENTS FOR VERY DISTAL LOWER EXTREMITY DISEASE CAUSING ADVANCED CLTI: OPTIONS TO SAVE THE “NO OPTION FOR TREATMENT” LIMB AND THE “DESERT FOOT”
What Presently Defines A No Option Or Desert Foot Before Or After Failed Endo Or Open Treatments: Under What Conditions Are Further Extreme Limb Salvage Procedures Possible
1:06 PM - 1:11 PM
Presenter
SESSION 26: NEW DEVELOPMENTS IN DRUG COATED BALLOONS (DCBS) AND DRUG ELUTING STENTS (DESS): UPDATES ON RANDOMIZED CONTROLLED TRIALS (RCTS) AND BTK LESION TREATMENTS WITH DCBS AND DESS
4-Year Results Of An RCT Comparing Surveil DCBs (Surmodics) With In.Pact DCBs (Medtronic) For Treating FemPop Lesions: From The TRANSCEND Trial
10:24 AM - 10:29 AM
Presenter
SESSION 25: LOWER EXTREMITY TOPICS RELATED TO DRUG COATED BALLOONS (DCBS), AND DRUG ELUTING STENTS (DESS) AND OTHER INTERWOVEN (SUPERA) STENTS
One View On The Final Result Of The Scare And Concern That Paclitaxel Coated Devices For Lower Extremity Treatments Increased Mortality And Amputation Rates: The Case Is Closed: What Were Its Costs
9:00 AM - 9:05 AM
Presenter
SESSION 35: RECORDED LIVE CHALLENGING CASES AND INNOVATIVE TECHNIQUES FROM THE PLINIO ROSSI AND LINC COMPONENTS
Distal Micro-Embolization During Complex Endovascular Procedures – The Underestimated Threat
1:40 PM - 1:45 PM
Presenter
SESSION 78: CAROTID ARTERY THERAPY STARS AND LATEST TRENDS
TCAR Is Better Than True Percutaneous Carotid Stenting: Myth Or Reality
11:09 AM - 11:16 AM
Presenter
SESSION 80: NEW DEVELOPMENTS IN THE TREATMENT OF CAROTID STENOSIS: UPDATE ON MESH COVERED STENTS AND TCAR (TRANSCERVICAL CAROTID ARTERY REVASCULARIZATION)
TCAR Is Safe In Recently Symptomatic Patients And Those With Contralateral Carotid Occlusions: Why TCAR Should Be The Procedure Of Choice In These Conditions
9:12 AM - 9:17 AM
Session Moderator
SESSION 106: MISCELLANEOUS/GENERAL TOPICS AND LOWER EXTREMITY TOPICS TOO IMPORTANT TO MISS
Presenter
SESSION 106: MISCELLANEOUS/GENERAL TOPICS AND LOWER EXTREMITY TOPICS TOO IMPORTANT TO MISS
Paclitaxel Use In CLTI Patients: Is There Still Any Evidence Of An Increased Amputation Risk
8:06 AM - 8:11 AM
Presenter
SESSION 107: MORE LOWER EXTREMITY TOPICS TOO IMPORTANT TO MISS
Can The BEST-CLI Trial Tell Us Whether Saving A Limb Also Prolongs Survival
9:08 AM - 9:13 AM